Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.
Oka Y, Tsuboi A, Murakami M, Hirai M, Tominaga N, Nakajima H, Elisseeva OA, Masuda T, Nakano A, Kawakami M, Oji Y, Ikegame K, Hosen N, Udaka K, Yasukawa M, Ogawa H, Kawase I, Sugiyama H.
Oka Y, et al. Among authors: ogawa h.
Int J Hematol. 2003 Jul;78(1):56-61. doi: 10.1007/BF02983241.
Int J Hematol. 2003.
PMID: 12894852
Clinical Trial.